The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Open accessAbstract
The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,053
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J. P., Keller, J. J., Westerman, A. M., Scott, R. J., Lim, W., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0083 · Cited by 855
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794
Inherited Mutations in Women With Ovarian Carcinoma
Norquist, B. M., Harrell, M. I., Brady, M. F., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Yi, Q., Burger, R. A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5495 · Cited by 769
Self-citationCouch, F. J., Hart, S. N., Sharma, P., Toland, A. E., Wang, X., Miron, P., Olson, J. E., Godwin, A. K., Pankratz, V. S., Olswold, C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1414 · Cited by 672
Self-citationSpectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
Self-citationFamily history and the risk of breast cancer: A systematic review and meta-analysis
Pharoah, P. D. P., Day, N. E., Duffy, S., Easton, D. F., & Ponder, B. A. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<800::aid-ijc18>3.0.co;2-b · Cited by 651
Pharoah, P. D. P., Guilford, P., & Caldas, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.29611 · Cited by 638
The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome
Watson, P., Vasen, H. F. A., Mecklin, J., Bernstein, I., Aarnio, M., Järvinen, H. J., Myrhøj, T., Sunde, L., Wijnen, J. T., & Lynch, H. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23508 · Cited by 596
Tung, N., Lin, N. U., Kidd, J., Allen, B. A., Singh, N., Wenstrup, R. J., Hartman, A.-R., Winer, E. P., & Garber, J. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.0747 · Cited by 556
Self-citationGermline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
Genetics of breast cancer: a topic in evolution
Shiovitz, S., & Korde, L. A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv022 · Cited by 525
(2004) · The American Journal of Human Genetics · doi:10.1086/421251 · Cited by 471
Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer
Kaurah, P., MacMillan, A., Boyd, N., Senz, J., De Luca, A., Chun, N., Suriano, G., Zaor, S., Van Manen, L., Gilpin, C., et al. (2007) · JAMA · doi:10.1001/jama.297.21.2360 · Cited by 447
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Ramus, S. J., Song, H., Dicks, E., Tyrer, J. P., Rosenthal, A. N., Intermaggio, M. P., Fraser, L., Gentry-Maharaj, A., Hayward, J., Philpott, S., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv214 · Cited by 437
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Uusitalo, E., Rantanen, M., Kallionpää, R. A., Pöyhönen, M., Leppävirta, J., Ylä-Outinen, H., Riccardi, V. M., Pukkala, E., Pitkäniemi, J., Peltonen, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3576 · Cited by 418
Mutations in BRIP1 confer high risk of ovarian cancer
Rafnar, T., Gudbjartsson, D. F., Sulem, P., Jonasdottir, A., Sigurdsson, A., Jonasdottir, A., Besenbacher, S., Lundin, P., Stacey, S. N., Gudmundsson, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.955 · Cited by 406
Stoffel, E. M., Mangu, P. B., Gruber, S. B., Hamilton, S. R., Kalady, M. F., Lau, M. W. Y., Lu, K. H., Roach, N., & Limburg, P. J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.1322 · Cited by 373
Hereditary Breast Cancer: The Era of New Susceptibility Genes
Apostolou, P., & Fostira, F. (2013) · BioMed Research International · doi:10.1155/2013/747318 · Cited by 351
Counselling framework for moderate-penetrance cancer-susceptibility mutations
Tung, N., Domchek, S. M., Stadler, Z., Nathanson, K. L., Couch, F., Garber, J. E., Offit, K., & Robson, M. E. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.90 · Cited by 314
Self-citationLancaster, J. M., Powell, C. B., Chen, L.-M., & Richardson, D. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.09.009 · Cited by 298
Integrated analysis of germline and somatic variants in ovarian cancer
Kanchi, K. L., Johnson, K. J., Lu, C., McLellan, M. D., Leiserson, M. D. M., Wendl, M. C., Zhang, Q., Koboldt, D. C., Xie, M., Kandoth, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4156 · Cited by 296
Järvinen, H. J., Renkonen-Sinisalo, L., Aktán-Collán, K., Peltomäki, P., Aaltonen, L. A., & Mecklin, J.-P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7784 · Cited by 282
Zhang, B., Beeghly-Fadiel, A., Long, J., & Zheng, W. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70076-6 · Cited by 272
Germline RAD51C mutations confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (BCSC) (UK), Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., Warren-Perry, M., Snape, K., Eccles, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2224 · Cited by 252
Sharif, S., Moran, A., Huson, S. M., Iddenden, R., Shenton, A., Howard, E., & Evans, D. G. R. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.049346 · Cited by 242
ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility
Broeks, A., Urbanus, J. H. M., Floore, A. N., Dahler, E. C., Klijn, J. G. M., Rutgers, E. J. T., Devilee, P., Russell, N. S., van Leeuwen, F. E., & van't Veer, L. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302746 · Cited by 240
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Casadei, S., Norquist, B. M., Walsh, T., Stray, S., Mandell, J. B., Lee, M. K., Stamatoyannopoulos, J. A., & King, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3958 · Cited by 240
A prospective study of neurofibromatosis type 1 cancer incidence in the UK
Walker, L., Thompson, D., Easton, D., Ponder, B., Ponder, M., Frayling, I., & Baralle, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603227 · Cited by 240
Dove‐Edwin, I., Boks, D., Goff, S., Kenter, G. G., Carpenter, R., Vasen, H. F. A., & Thomas, H. J. W. (2002) · Cancer · doi:10.1002/cncr.10380 · Cited by 227
Rare variants in the ATMgene and risk of breast cancer
Goldgar, D. E., Healey, S., Dowty, J. G., Da Silva, L., Chen, X., Spurdle, A. B., Terry, M. B., Daly, M. J., Buys, S. M., Southey, M. C., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2919 · Cited by 226
Self-citationPALB2/FANCN: Recombining Cancer and Fanconi Anemia
Tischkowitz, M., & Xia, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1012 · Cited by 198
Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome
Renkonen‐Sinisalo, L., Bützow, R., Leminen, A., Lehtovirta, P., Mecklin, J., & Järvinen, H. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22446 · Cited by 195
van Os, N. J. H., Roeleveld, N., Weemaes, C. M. R., Jongmans, M. C. J., Janssens, G. O., Taylor, A. M. R., Hoogerbrugge, N., & Willemsen, M. A. A. P. (2016) · Clinical Genetics · doi:10.1111/cge.12710 · Cited by 191
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Thompson, E. R., Rowley, S. M., Li, N., McInerny, S., Devereux, L., Wong-Brown, M. W., Trainer, A. H., Mitchell, G., Scott, R. J., James, P. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.7454 · Cited by 183
Gynecologic screening in hereditary nonpolyposis colorectal cancer
Rijcken, F. E. M., Mourits, M. J. E., Kleibeuker, J. H., Hollema, H., & van der Zee, A. G. J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00371-8 · Cited by 170
Bernstein, J. L., Haile, R. W., Stovall, M., Boice, J. D., Shore, R. E., Langholz, B. M., Thomas, D. C., Bernstein, L., Lynch, C. F., Olsen, J. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq055 · Cited by 151
Nijmegen Breakage Syndrome mutations and risk of breast cancer
Bogdanova, N. V., Feshchenko, S., Schürmann, P., Waltes, R., Wieland, B., Hillemanns, P., Rogov, Y., Dammann, O., Bremer, M., Karstens, J. H., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23168 · Cited by 143
Kuusisto, K. M., Bebel, A., Vihinen, M., Schleutker, J., & Sallinen, S. (2011) · Breast Cancer Research · doi:10.1186/bcr2832 · Cited by 131
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2011.10.021 · Cited by 121
Auranen, A., & Joutsiniemi, T. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01091.x · Cited by 118
Easton, D. F., Lesueur, F., Decker, B. J., Michailidou, K., Li, J., Allen, J., Luccarini, C., Pooley, K. A., Shah, M., Bolla, M. K., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103529 · Cited by 109
Gynecologic Cancer Prevention in Lynch Syndrome/Hereditary Nonpolyposis Colorectal Cancer Families
Chen, L.-M., Yang, K. Y., Little, S. E., Cheung, M. K., & Caughey, A. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000267500.27329.85 · Cited by 104
Age-specific risk of breast cancer in women with neurofibromatosis type 1
Seminog, O. O., & Goldacre, M. J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.78 · Cited by 84
Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I
Nishida, T., Tsujimoto, M., Takahashi, T., Hirota, S., Blay, J., & Wataya‐Kaneda, M. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1132-6 · Cited by 78
Zhang, G., Zeng, Y., Liu, Z., & Wei, W. (2013) · Tumor Biology · doi:10.1007/s13277-013-0830-z · Cited by 70
Breast-Cancer Risk in Families with Mutations in PALB2
Thomas, P., & Brown, P. (2015) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2015.07.017 · Cited by 67
Stoffel, E. M., Mangu, P. B., & Limburg, P. J. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.003665 · Cited by 64
Clinical/genetic features in hereditary breast cancer
Lynch, H. T., Watson, P. A., Conway, T., & Lynch, J. F. (1990) · Breast Cancer Research and Treatment · doi:10.1007/bf01810778 · Cited by 61
ATM variants and cancer risk in breast cancer patients from Southern Finland
Tommiska, J., Jansen, L., Kilpivaara, O., Edvardsen, H., Kristensen, V. N., Tamminen, A., Aittomäki, K., BLOMQVIST, C. P., Børresen‐Dale, A., & Nevanlinna, H. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-209 · Cited by 27
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America
Iniesta, M. D., Gorin, M. A., Chien, L.-C., Thomas, S. M., Milliron, K. J., Douglas, J. A., & Merajver, S. D. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.07.124 · Cited by 22
Self-citationWood, N. J., Duffy, S., & Sheridan, E. G. (2003) · Cancer · doi:10.1002/cncr.11704 · Cited by 18
Evans, D. G. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35585 · Cited by 13
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
(2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000203664.61138.5b · Cited by 6
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Lheureux, S., Braunstein, M., & Oza, A. M. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21559 · Cited by 1,423
State-of-the-art strategies for targeting the DNA damage response in cancer
Pilié, P. G., Tang, C., Mills, G. B., & Yap, T. A. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0114-z · Cited by 1,189
Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 961
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Metadata
- Authors
- Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., Kohlmann, W., Kurian, A., Litton, J. K., Madlensky, L., Merajver, S. D., Offit, K., Pal, T., Reiser, G., Shannon, K. M., Swisher, E., Vinayak, S., Voian, N. C., Weitzel, J. N., Wick, M. J., Wiesner, G. L., Dwyer, M., & Darlow, S.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2016-12-31
- Volume
- 15
- Issue
- 1
- Pages
- 9-20
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2579423964
- Cited by
- 650
- References
- 56
- FWCI
- 83.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.